article thumbnail

RCE Technologies, Inc. Announces First-In-Human Transdermal Continuous Cardiac Biomarker Monitoring

DAIC

This is an innovative platform for measuring biomarkers,” stated Dr. Karlsberg. This study highlights the value of digital biomarkers that may enable instantaneous feedback for care providers in assessing the patient. Featured in an ACC.24

article thumbnail

Bodyport Presents Preliminary Analysis of SCALE-HF 1 Study on Remote Heart Failure Monitoring at Technology and Heart Failure Therapeutics (THT) Conference

DAIC

a biomarker-guided predictive care company, has presented data showing its FDA-cleared, non-invasive, biomarker-based technology for remote heart failure monitoring detected twice as many heart failure events as compared to the weight-based standard of care. Bodyport Inc., Image courtesy: Bodyport Inc.

article thumbnail

Thrombosis, Translational Medicine, and Biomarker Research: Moving the Needle

Journal of the American Heart Association

Despite significant advances in the diagnosis, prognostication, and treatment of thrombotic diseases over the past 3 decades, the adoption of findings stemming from translational biomarker research in clinical practice remains limited. They hold the promise of revolutionizing patient care.

article thumbnail

The Cardiometabolic Event of the Year: What to Expect at the 19th Annual Cardiometabolic Health Congress (CMHC) 

Cardiometabolic Health Congress

A jam-packed, expertly curated agenda will highlight the latest and most impactful advancements in cardiorenal metabolic medicine and protocols for future-focused, whole-patient care.

Education 100
article thumbnail

HeartBeam Unveils AI Program Designed to Deliver Unprecedented Personalized Cardiac Insights

DAIC

“By pioneering a user-friendly device that enables frequent 12-lead ECGs over time and by coupling AI with our proprietary VECG technology that can go beyond a 12-lead ECG, HeartBeam is well-positioned to identify nuanced cardiac trends that could ultimately improve patient care.”

article thumbnail

Top 10 Cardiac Diagnosis Trends in 2024

GEMMS

These advancements, alongside software enhancements, enable early detection of cardiac diseases, empowering healthcare providers to make evidence-based decisions and tailor appropriate patient care plans. Innovative algorithms analyze gene biomarkers to provide predictive insights and personalized patient therapy.

article thumbnail

Creative Alliances in Cardiorenal Metabolic Management: A Game Changer (Part 1) 

Cardiometabolic Health Congress

One promising strategy is the formation of creative partnerships between patients and their healthcare teams. We can revolutionize patient care and significantly reduce cardiometabolic risk by fostering collaborative relationships and leveraging diverse expertise and experiences.